CHIMERA (Closed Head Impact Model of Engineered Rotational Acceleration) is a recently described animal model of traumatic brain injury (TBI) that primarily produces diffuse axonal injury (DAI) characterized by white matter inflammation and axonal damage. CHIMERA was specifically designed to reliably generate a variety of TBI severities using precise and quantifiable biomechanical inputs in a nonsurgical user-friendly platform. The objective of this study was to define the lower limit of single impact mild TBI (mTBI) using CHIMERA by characterizing the dose-response relationship between biomechanical input and neurological, behavioral, neuropathological and biochemical outcomes. Wild-type male mice were subjected to a single CHIMERA TBI using six impact energies ranging from 0.1 to 0.7 J, and post-TBI outcomes were assessed over an acute period of 14 days. Here we report that single TBI using CHIMERA induces injury dose-and time-dependent changes in behavioral and neurological deficits, axonal damage, white matter tract microgliosis and astrogliosis. Impact energies of 0.4 J or below produced no significant phenotype (subthreshold), 0.5 J led to significant changes for one or more phenotypes (threshold), and 0.6 and 0.7 J resulted in significant changes in all outcomes assessed (mTBI). We further show that linear head kinematics are the most robust predictors of duration of unconsciousness, severity of neurological deficits, white matter injury, and microgliosis following single TBI. Our data extend the validation of CHIMERA as a biofidelic animal model of DAI and establish working parameters to guide future investigations of the mechanisms underlying axonal pathology and inflammation induced by mechanical trauma. Crown
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Introduction
Traumatic brain injury (TBI) is a leading worldwide cause of death and disability in persons under 45 years of age with an annual cost of over $80B (Faul and Coronado, 2015) . Over 2 million TBIs occur every year in the United States, mostly from falls, motor vehicle accidents and sports (Faul and Coronado, 2015) . The Glasgow Coma Scale (GCS), developed in 1974 by Graham Teasdale and Brain Jennet (Teasdale and Jennett, 1974) , is widely used to assess a patient's level of consciousness using eye, verbal and motor responses to classify TBI into categories of mild , moderate and severe (GCS 3-7) (United Sates Departments of Defense and Veterans Affairs, 2008) . Current data from the Centers for Disease Control and Prevention show that approximately 75% of TBI cases are mild, and most occur in two major age groups including children-young adults and the elderly (Faul and Coronado, 2015) .
Although the term "concussion" is often used interchangeably with mild TBI (mTBI) (Levin and Diaz-Arrastia, 2015) , it is important to realize that human concussion is defined by nonspecific clinical criteria such as confusion, amnesia, disorientation, or headache. It has long been recognized that clinically observable features, such as presence and duration of unconsciousness, duration of post-traumatic amnesia, and GCS on presentation are poor predictors of outcome and correlate weakly with neurodegeneration. In recent years, several schemes have been developed to sub-categorize mTBI (Kamins and Giza, 2016) . Currently, mTBI is defined as GCS 13-15 within 24 h of impact, and complicated mTBI is defined as mTBI combined with intracranial imaging findings. Concussion is defined as a "clinical syndrome in which a biomechanical force, via acceleration-deceleration or rotational forces, transiently disturbs normal brain function, causing neurological-cognitive-behavioral signs and symptoms" (Kamins and Giza, 2016) . Subconcussion is a "proposed construct of biomechanical force causing subclinical injury in the absence of overt acute signs and symptoms" (Kamins and Giza, 2016) . These definitions are in flux, and many expect the current clinical classification scheme will eventually be replaced by one based on biomarkers that more closely reflects the underlying pathophysiology (Diaz-Arrastia et al., 2014; Saatman et al., 2008) .
Although historically considered benign, mTBI can result in significant disability. Most mTBI patients recover without sequelae, yet approximately 10% have intracranial lesions on computed tomography scanning (complicated mTBI) and a minority of these can develop a potential life-threatening condition that requires neurosurgical intervention (Haydel et al., 2000) . Additionally, up to 30% of mTBI subjects, despite having normal neuroimaging, can suffer persistent impairment of physical, cognitive, and psychosocial functioning known as post-concussive syndrome (Carroll et al., 2014) . The recognized incidence of mTBI complications and poor outcomes is rising, owing to greater awareness and reporting especially for sports-related concussion.
Although the monetary cost of TBI varies by severity, the high incidence of mTBI leads to a total cost that is nearly three times that for moderate to severe TBI (Te Ao et al., 2014) . The prevalence and socioeconomic burden of mTBI are driving the demand to develop objective diagnostic, prognostic and therapeutic tools to address this large unmet medical need.
A major gap in clinical TBI research, especially for mTBI, is the lack of human brain specimens to study, as human brain tissues are only available under extreme life-threatening circumstances, or at postmortem where the time between injury and autopsy can be highly variable. Cerebrospinal fluid (CSF), which has been invaluable for the development of biomarkers of neurodegenerative disease, is rarely obtained after TBI. Blood specimens are being collected in several clinical TBI studies and several promising blood TBI biomarkers are emerging (Bogoslovsky et al., 2016; Oresic et al., 2016; Shahim et al., 2016; Zetterberg and Blennow, 2016) . Still, how blood biomarkers may reflect brain changes after TBI is not yet clear.
Experimental TBI animal models from which pre-injury and longitudinal data can be obtained and from which brain biospecimens can be collected under controlled conditions therefore have considerable potential to address a multitude of questions about the tissue level mechanisms of mTBI and the factors that modulate mTBI recovery and repair. Popular rodent TBI models include open-head injury models including fluid percussion (FP) and controlled cortical impact (CCI) systems, and closed-head injury (CHI) models that use either gravity or mechanical methods to impact the intact skull [reviewed in (Namjoshi et al., 2013a) ]. Although FP and CCI models employ highly reproducible mechanical inputs and can mimic many pathological features of human TBI, their predominately focal tissue destruction and lack of head movement decreases their resemblance to the majority of human impact acceleration injuries, which most often occur without skull fracture and are chiefly characterized by diffuse axonal injury (DAI). The importance Fig. 1 . Head kinematics during CHIMERA TBI. Head kinematics during single impact for was assessed in mice subjected to single TBI of varying impact energies from 0.1 to 0.7 J (N = 8-10/ impact energy group), that were binned into categories reflecting subthreshold, threshold and mTBI groups. The graphs depict peak values of linear (A-C) and angular (D-F) head kinematic parameters over different impact energies. Data are presented as mean ± SD. Data were analyzed by one-way ANOVA followed by a Tukey post-hoc test. Asterisks (*) denote significant difference compared to the lowest energy group (i.e., sub-threshold). Hash (#) denote significant differences between energy groups other than 0.1 J. For each graph, * and #: p b 0.05, ** and ##: p b 0.01, *** and ###: p b 0.001, **** and ####: p b 0.0001. of understanding the relationship between biomechanical inputs and pathological responses in TBI is increasingly being recognized (Coats et al., 2017; Courtney and Courtney, 2015; Cullen et al., 2016; Namjoshi et al., 2014) .
We recently developed a neurotrauma animal model called CHIME-RA (Closed-Head Impact Model of Engineered Rotational Acceleration) to address the absence of a simple, nonsurgical impact acceleration model of CHI that reliably produces DAI and white matter inflammation. We previously showed that mice subjected to two mild, closed-head TBIs with an impact energy of 0.5 J using CHIMERA show human-like head kinematics and faithfully reproduce behavioral features and diffuse white matter tract pathology similar to human TBI (Namjoshi et al., 2014) . However, much remains to be learned about the parameters of the nascent CHIMERA technology to substantiate it as a useful platform for the TBI research community. This study was therefore defined to establish the threshold energy for single impact mTBI in the sagittal plane and to test the hypothesis that CHIMERA mechanical inputs predict behavioral and neuropathological outcomes in mice.
Materials and methods

CHIMERA TBI procedure and high speed videography
All animal procedures were approved by the University of British Columbia Committee on Animal Care and were carried in strict accordance with the Canadian Council on Animal Care guidelines. Male C57Bl/6 mice (mean ± SD body weight: 33.05 ± 3.63 g) at 4-5 months of age (mean ± SD age: 4.44 ± 0.56 months) were housed with a reversed 12 h light-12 h dark cycle. Animals were prepared for single TBI in the sagittal plane using CHIMERA as described (Namjoshi et al., 2014) . Briefly, mice received isofluorane anesthesia (mean ± SD total isoflurane exposure duration: 278.67 ± 60.77 s) and were positioned on the CHIMERA impactor. TBI animals received a single closed-head impact at 0.1, 0.3, 0.4, 0.5, 0.6 or 0.7 J of energy using a 50-g stainless steel piston. Sham animals (0 J) received an equivalent isofluorane exposure as TBI animals but experienced no impact. Five to six animals were included per energy group per post-TBI time point (described below). Head kinematics at each impact energy were assessed using high-speed (9000 fps) videography with two reference points including a snout and a cheek marker, and were analyzed by ProAnalyst motion analysis software (Xcitex Inc., Woburn, MA) as described (Namjoshi et al., 2014) . Pre-TBI body weight, age at TBI and isoflurane exposure duration were comparable across all impact energy groups ( Supplementary  Fig. S1 ).
The Head Injury Criterion (HIC) was calculated using Eq. (1). The HIC quantifies head impact severity by incorporating the acceleration magnitude and duration of acceleration exposure. The resultant linear head acceleration (a), measured in g, was used to calculate HIC with a time interval (t 2 − t 1 ) chosen to maximize HIC over a maximum duration of 15 ms.
Scaling mouse head kinematic insults to equivalent relations in humans used a single scale factor of 13.8 (λ) and followed the equal stress equal velocity relationship as described by Ommaya et al. (Ommaya et al., 1967) and summarized by Panzer et al. (Panzer et al., 2014) .
Behavioral analyses
Behavioral analyses were performed as described (Namjoshi et al., 2014; Namjoshi et al., 2013b) . Briefly, duration of loss of righting reflex (LRR) was recorded immediately following head impact. Neurological impairment was assessed using the neurological severity score (NSS) at 1 h post-TBI. Motor function was assessed using the accelerating rotarod test at 1, 2, 7 and 14 d post-TBI. Anxiety-like thigmotactic behavior was assessed in an open field at 1 and 7 d after TBI. Post-TBI anxiety behavior was further tested with the elevated plus maze (EPM) at 2 d post-TBI. For EPM testing, the animal was placed in the central zone of a custom-built EPM and spontaneous activity was recorded using AnyMaze (Stoelting Co., Wood Dale, IL) for 5 min to assess time spent in the open and closed arms.
Tissue collection
Brains were collected at 6 h and at 1, 2, 7 and 14 d post-TBI as described (Namjoshi et al., 2014; Namjoshi et al., 2013b) . Briefly, animals were anesthetized with ketamine and xylazine and perfused with icecold heparinized phosphate-buffered saline (PBS). Brains were rapidly collected, longitudinally bisected and hemibrains were processed for histology or biochemistry as described (Namjoshi et al., 2014; Namjoshi et al., 2013b) .
Histological analyses
Hemibrains were cyroprotected with 30% sucrose and 40 μm coronal sections were prepared using a cryostat. Three to five coronal sections per brain spanning the olfactory bulb to the posterior hippocampus were assessed for histology as described below. Microglial activation and axonal damage were assessed using Iba1 immunohistochemistry and silver staining, respectively, as described (Namjoshi et al., 2014; Namjoshi et al., 2013b) . Astrocyte reactivity was assessed with glial acidic fibrillary protein (GFAP) immunohistochemistry. Briefly, coronal brain sections were treated with 0.3% hydrogen peroxide for 10 min and blocked with 5% normal goat serum (NGS) in PBS for 1 h. Sections were incubated overnight at 4°C with rabbit anti-mouse GFAP antibody (Abcam, AB305808, 1:500) in 5% NGS. After washing in PBS, the sections were incubated with a biotinylated goat anti-rabbit secondary antibody (1:1000 in PBS) for 1 h at room temperature. Sections were stained with horseradish peroxidase (Vectastain Elite ABC Kit PK-6120, Vector Laboratories (Canada) Inc., Burlington, ON) and DAB substrate, mounted and dehydrated.
All stained sections were digitally imaged at a commercial histology service (Wax-it Histology Services Inc., Vancouver, BC) with a ScanScope CS-R scanner (Aperio Technologies) using a 20X magnification objective lens. From the whole-mount images, 20X magnified images containing regions of interest were extracted using the Aperio ImageScope Viewer (v. 12.2.2.2015, Aperio Technologies) software.
Image analyses
Image quantification was carried out with ImageJ (1.51f, NIH). The microglial response was quantified by counting the number of Iba1-positive cells in white matter regions as described (Namjoshi et al., 2014) . The astrocyte response was quantified by counting GFAP-positive cells in the corpus callosum. Silver staining was assessed by quantifying percent stained area of the region of interest of white matter as described (Namjoshi et al., 2014) .
Biochemical analyses
Half-brains were homogenized in 1.5 ml of ice-cold RIPA lysis buffer containing 0.1 mM phenylmethylsulfonyl fluoride, complete protease inhibitor (Roche Applied Science), and PhosSTOP tablets (Roche Applied Science) in a Tissuemiser homogenizer at full speed for 20 s and then sonicated at 20% output for 10 s. After incubating on ice for 10 min, lysates were clarified by centrifugation at 9000 rpm for 10 min at 4°C and the supernatant was taken for analysis. Levels of IL-6, IL-1β and TNFα were measured on lysates diluted 1:2 using a customized version of the V-PLEX Proinflammatory Panel 1 (mouse) (K152A0H-2, Meso Scale Discovery, Rockville, MD) following the manufactures protocol, with the exception that sample incubation was increased to overnight at 4°C. Levels of total and phosphorylated (Thr231) tau were measured on samples diluted 1:50 using a MSD® MULTI-SPOT assay (K15121D-2, Meso Scale Discovery, Rockville, MD) following the manufacturers protocol. Plates were read on a SECTOR S 600 plate reader (Meso Scale Discovery, Rockville, MD) and concentrations were normalized to total protein content determine by bicinchoninic acid assay (Pierce).
Statistical analyses
All statistical analyses were performed using GraphPad Prism (v. 6.07) unless otherwise stated. Peak head kinematic parameters data were analyzed with one-way ANOVA followed by Tukey post-hoc tests. LRR and 1 h NSS data were analyzed with Kruskal-Wallis test. Rotarod latencies and thigmotaxis index data were analyzed with a linear mixed model using SPSS Statistics (v.23, IBM Corporation). Histological quantification and EPM data were analyzed with two-way ANOVA followed by Tukey post-hoc tests. Correlation analyses were employed to assess the relationships between head kinematic data and post-TBI outcomes including LRR, 1 h NSS, silver stain quantification, and Iba1-positive cell count using Spearman's rank correlation coefficient. All data are presented as mean ± SD unless otherwise stated.
Results
Data binning
One of the objectives of the current study was to determine the lower limit of impact energy required to induce significant alteration(s) in one or more of our post-TBI outcomes (kinematics, behavior and neurological deficits, neuropathology and biochemical changes) compared to sham controls. Initial analysis of each energy group showed that impact energies from 0.1-0.4 J caused no significant changes in any post-TBI behavioral and neuropathological outcome compared to the uninjured group. Significant changes in at least one measure of behavior and neuropathology were observed at impact energy of 0.5 J, and impact energies of 0.6 and 0.7 J produced significantly more injury than 0.5 J but were not significantly different from each other (not shown). Accordingly, we binned data from the seven energy groups into four categories: Sham (0 J), sub-threshold (0.1, 0.3 and 0.4 J), threshold (0.5 J) and mild TBI (mTBI, 0.6 and 0.7 J). The analyses reported hereafter represent binned data obtained from a total of N = 31 mice in the sham category, N = 94 mice in the subthreshold category, N = 36 mice in the threshold category, and N = 65 mice in the mTBI category. Experiments were designed with the target sample size of 5-6/energy group/time point for biochemical and histological analyses. We achieved the target N for all assays except for the quantitative analysis of tau where for the sham group we used N = 2/time point/energy group. The limited space on the assay plates precluded us from running all samples from all time points at the same time. The details of sample size for each analysis are presented in Supplementary Table (Fig. S2) .
Single impact CHIMERA induces energy dose-dependent changes in head kinematics
We assessed changes in head kinematics by analyzing peak linear (head displacement, velocity and acceleration) and angular (angle, velocity and acceleration) kinematic parameters over increasing impact energies. Each parameter showed an impact energy dose-dependent increase (Fig. 1) . Except for head angle, we observed significant impact energy dose effects for all other head kinematic parameters [Displacement: F(2, 53) = 15.21, p b 0.0001; Linear Velocity: F(2, 53) = 24.62, p b 0.0001; Linear Acceleration: F(2, 53) = 19.58, p b 0.0001; Angle: F(2, 52) = 2.445, p = 0.0966; Angular Velocity: F(2, 53) = 31.37, p b 0.0001; Angular Acceleration: F(2, 52) = 15.71, p b 0.0001; Oneway ANOVA followed by Tukey's post-hoc test]. Post-hoc analyses revealed that increasing impact energies caused a significant increase in all head kinematic values except head angle compared to the subthreshold TBI group (Fig. 1) .
The mean ± SD HIC15 values scaled to human for the sub-threshold, threshold and mTBI groups were 43.01 ± 51.33, 91.94 ± 39.55, and 108.4 ± 57.05, respectively.
3.3. Single impact CHIMERA induces energy dose-dependent increases in righting time, neurological severity, motor deficits and thigmotactic behavior
We recorded LRR duration immediately following closed head impact, which showed a robust injury dose effect ( Fig. 2A, p b 0 .0001, Kruskal-Wallis test). Post-hoc analysis showed that LRR durations of the threshold and mTBI groups were significantly longer compared to the sham and sub-threshold TBI groups ( Fig. 2A) . Mice in the mTBI group exhibited the longest post-TBI LRR duration compared all other groups ( Fig. 2A) . Similarly, the NSS determined at 1 h post-TBI also showed an overall injury dose effect (Fig. 2B, p b 0 .0001, Kruskal-Wallis test). Mice in the threshold and mTBI groups exhibited significantly higher NSS values compared to sham controls (Fig. 2B) . Post-TBI anxiety behaviors were assessed with the EPM and open-field thigmotactic behavior. For EPM we compared the number of entries by the animal in the open and closed arms of the maze and found no significant differences across any energy group (Fig. 2C, p N 0 .05, two-way ANOVA). By contrast, thigmotactic behavior showed significant impact energy dose (p = 0.016) and time (p b 0.0001) effects (Fig. 2D, linear mixed  model) . Post-hoc analysis showed significantly increased thigmotactic behavior of mice in the mTBI group compared to sham and sub-threshold TBI groups regardless of time. However, thigmotactic behavior did not show a significant impact energy x time interaction (p = 0.559, linear mixed model). We assessed post-TBI motor deficits using the accelerating rotarod task. Analysis of rotarod latencies revealed significant effects of impact energy dose (p b 0.0001) and time (p b 0.0001), and revealed a significant interaction of impact energy dose x time (p b 0.001) (Fig. 2E, linear mixed model) . Post-hoc analysis of impact energy dose revealed significantly reduced rotarod latencies of mice in the mTBI group, while fall latencies of mice in sham, sub-threshold and threshold TBI groups were comparable over all post-TBI time points tested. Mice in the mTBI group exhibited sustained motor deficits compared to the sham group over all post-TBI time points except 7 d (Fig. 2E) .
Single impact CHIMERA induces energy dose-dependent increases in microgliosis, astrogliosis and proinflammatory cytokines
The post-TBI microglial response was assessed with Iba1 immunohistochemistry at 6 h and 1, 2, 7 and 14 d post-TBI. Compared to sham brains, injured brains showed significant increases in the number of Iba1-positive microglia in several white mater regions including the optic tract (Fig. 3) , olfactory nerve layer ( Supplementary Fig. S3 ), corpus callosum ( Supplementary Fig. S4 ), and brachium of superior colliculus ( Supplementary Fig. S5 ), indicating that CHIMERA injury induced proliferation or recruitment of immune cells. In addition to white matter, we also noticed significant increases in Iba1-positive microglia in the lateral geniculate nucleus (Supplementary Fig. S6 ). Quantitative analysis of Iba1 images revealed an impact energy dose-dependent increase in the number of Iba1-positive microglia in the olfactory nerve layer (Fig. 4A , energy dose effect: F(3, 125) = 23.9, p b 0.0001), corpus callosum (Fig. 4B , energy dose effect: F(3, 130) = 26.58, p b 0.0001), brachium of superior colliculus (Fig. 4C , energy dose effect: F(3, 132) = 25.4, p b 0.0001) and optic tract (Fig. 4D , energy dose effect: F(3, 135) = 27.06, p b 0.0001). Microgliosis was significant in all white matter regions in the mTBI group. Microglia number showed persistent increases over 1-14 d in the olfactory nerve layer ( Finally, we observed a significant impact energy × time interaction in microglia number in the corpus callosum (Fig. 4B, F(12, 130) = 16.84, p = 0.0044), brachium of superior colliculus (Fig. 4C, F(12, 132) = 1.833, p = 0.0489) and optic tract (Fig. 4D , Time effect: F(4, 135) = 4.026, p b 0.0001), indicating that increased impact energy doses led to persistently increased microglial proliferation or recruitment over time. The temporal profile of post-TBI microgliosis also showed region-specificity. Thus, microgliosis in the olfactory nerve layer and corpus callosum showed an early peak at 2 d post-TBI, while that in the brachium of superior colliculus and optic tract peaked later at 7 d (Supplementary Fig.  S9A ).
We also assessed astrocyte activation at the same post-TBI time points by GFAP immunohistochemistry, and found a significant increase in the number of GFAP-positive astrocytes exclusively in the corpus callosum of injured animals (Fig. 5A ). Quantitative analysis of GFAP images showed significant effects for impact energy dose (Fig. 5B, F(3,  101) = 16.55, p b 0.0001) and time (F(4, 101) = 11.17, p b 0.0001), and revealed a significant energy dose × time interaction (F(12, 101) = 4.407, p b 0.0001). Astrogliosis peaked in the threshold and Fig. 9 . Quantification of endogenous tau levels. Endogenous and phospho(Thr231) tau levels in half-brain homogenates were assessed with a MSD® MULTI-SPOT assay kit. Levels of total tau (A), phospho (Thr231) tau (B) quantification and ratio of phospho:total tau (C) are presented as Mean ± SD. Data were analyzed by two-way ANOVA. Fig. 8 . Quantitative analysis of axonal pathology after single impact CHIMERA TBI. Silver stain images were quantified by calculating the % region of interest (ROI) in white matter areas that displayed silver uptake, including the olfactory nerve layer (A), corpus callosum (B) and optic tract (C). Graphs depict mean ± SD % of the ROI showing in sham and injury categories over time. Data were analyzed by two-way ANOVA followed by Tukey post-hoc test. * and #: p b 0.05, ** and ##: p b 0.01, *** and ###: p b 0.001, **** and ####: p b 0.0001. mTBI groups at 2 d, and showed persistent increase in mTBI group up to 7 d followed by return to baseline in all groups by day 14 (Fig. 5B) .
In addition to microglial and astrocyte response, we also measured protein levels of proinflammatory cytokines IL-6, IL-1β and TNFα in half-brain homogenates at 6 h. Protein levels of all the three proinflammatory cytokines were significantly higher than sham levels (Fig. 6 , p b 0.05, one-way ANOVA).
Single impact CHIMERA induces energy dose-dependent increases in axonal damage
We used silver staining to assess axonal pathology as a function of energy level and time after single impact CHIMERA. Compared to the sham group, injured brains showed widespread axonal injury, as indicated by intense punctate and fiber-associated argyrophilic structures in the optic tract (Fig. 7) , olfactory nerve layer ( Supplementary  Fig. S7 ), and corpus callosum (Supplementary Fig. S8 ). Quantification of silver stained images showed an impact energy dose effect in the olfactory nerve layer (Fig. 8A, F(3, 126) = 11.75, p b 0.0001), corpus callosum (Fig. 8B, F(3, 141) = 15.68, p b 0.0001) and optic tract (Fig. 8C, F(3, 125) = 33.26, p b 0.0001). Post-hoc testing revealed significantly higher silver uptake in all white matter regions by 2 d postinjury in the mTBI group compared to sham (Fig. 8) .
We also noticed region-specific changes in the temporal profile of silver uptake ( Fig. 8 and Supplementary Fig. S9B ). Thus, in mTBI group silver uptake was prominent in the olfactory nerve layer at 1 and 2 d followed by return to sham levels by day 7 (time effect We assessed endogenous levels of total and phosphorylated (Thr231) tau in half brain homogenates using a MSD® MULTI-SPOT assay (K15121D-2, Meso Scale Discovery). No significant changes were observed for total tau, phosphorylated tau, or the ratio of phosphorylated:total tau for any injury group at any time point tested (Fig. 9) .
Neurological and neuropathological outcomes following single CHIMERA TBI correlate significantly with linear head kinematics
We also tested for correlations between changes in the biomechanical response of the head following single impact CHIMERA injury in the sagittal plane with neurological and neuropathological outcomes at 2 d post-injury (Table 1) . We observed a strong positive correlation between linear head kinematic parameters with several post-TBI outcomes. Among all post-TBI outcomes, LRR showed the strongest positive correlation with both linear (displacement, velocity and acceleration) and angular (velocity and acceleration) head kinematic parameters (p b 0.0001). NSS at 1 h was positively correlated with head displacement (p = 0.0146), linear velocity (p = 0.006), linear acceleration (p = 0.0168) and angular velocity (p = 0.0011). The microglial response in all white matter regions showed a significant positive correlation with all three linear kinematic parameters but not with any angular kinematic parameters. Silver stain uptake in the olfactory nerve layer and corpus callosum showed a significant positive correlation with head displacement and linear velocity only, whereas, silver stain uptake in the optic tract showed a strong positive correlation with all three linear kinematic parameters.
Discussion
The neuropathology of TBI has historically been investigated using brain tissues from patients who succumbed within hours to weeks after severe TBI (Blennow et al., 2012; Johnson et al., 2013) . More recently, the neuropathological hallmarks of chronic traumatic encephalopathy (CTE) have been defined using brain tissues obtained from athletes in high contact sports, often years after their peak of exposure to repetitive mTBI (McKee et al., 2016) . These various streams continue to provide tremendous value in understanding the neuropathology of severe and repetitive mTBI, yet, the degree to which they are representative of a single mTBI remains unknown. Additionally, although impact tolerance thresholds (i.e., the applied force at which injury occurs) for skull fracture have been determined using cadaver studies (Hodgson Table 1 Summary of correlation analyses. The table summarizes the results of correlation analyses testing associations among linear and angular head kinematic parameters with post-TBI neurological and neuropathological outcomes. For each correlation pair, the respective coefficient of determination is presented in the upper row, while the corresponding p value is indicated in lower row. Significant correlations (p b 0.05) are highlighted in bold. and Thomas, 1971; Yoganandan et al., 1995) , the corresponding acceleration-deceleration force tolerances of living brain tissue for structural damage (brain contusion, DAI etc.) and functional disturbances (sensory, cognitive, and motor deficits) are not well understood. Current knowledge relies primarily on injury reconstructions using anthropometric test devices, finite element models of the brain and head or helmet-mounted acceleration measurements in athletes (Kleiven, 2007; Pellman et al., 2003; Zhang et al., 2004) . As single mTBI represents the largest proportion of head injuries that bring people to medical attention, it is increasingly important to understand what severity of impact the living brain can experience without triggering pathological responses that can have long-term consequences. Further, once brain tissue injury tolerance levels are exceeded, it is equally important to define which are the most sensitive potential diagnostic and prognostic markers, and to understand how the temporal profiles of these markers change as a function of acceleration-deceleration force and time. This study was, therefore, designed to leverage the advantages of the CHIMERA platform to define the lower limit of mTBI in mice upon a single impact in the sagittal plane. Here we show that impact energies up to 0.4 J, which lead to average peak linear and angular accelerations of 305 g and 86.9 krad/s 2 respectively, do not produce any significant phenotype except for Iba1 reactivity in the optic tract and brachium of superior colliculus at 14d, and can thus be considered sub-threshold. An impact energy of 0.5 J, which produced average peak linear and angular accelerations of 510 g and 149 krad/s 2 respectively, resulted in significant changes in behavioral (LRR and NSS), and histopathological (Iba1 reactivity in corpus callosum, brachium of superior colliculus and optic tract, and GFAP reactivity in corpus callosum) outcomes, and is defined as the threshold of acute injury for murine CHIMERA. Impact energies of 0.6 and 0.7 J resulted in average peak linear and angular accelerations of 539 g and 183 krad/s 2 , respectively, and led to robust and significant changes for many behavioral (LRR, NSS, thigmotaxis, rotarod), and histopathological (Iba1 reactivity and silver uptake in all white matter tracts examined, and GFAP reactivity in corpus callosum), and can be considered in the mTBI range. Using the current CHIMERA piston design, impact energies N 0.7 J resulted in skull fracture and posed an ethical upper limit to our studies. These results demonstrate that single impact CHIMERA in the sagittal plane effectively models both behavioral and histopathological phenotypes of diffuse axonal injury. Our results define critical experimental parameters that can now be used to determine how well our categories of subthreshold, threshold and mTBI groups using murine CHIMERA reflect human subconcussive, concussive and mTBI categories. Importantly, current definitions that categorize human mTBI are thus far based on clinical and neuroimaging approaches. Our study employed several behavioral measures reminiscent of clinical measures, including LRR as a proxy of loss of consciousness, NSS as a proxy of neurological outcomes, EPM and open field analyses as proxies for anxiety, and rotarod latency as a proxy of motor function and coordination. We observed that LRR and NSS are the most sensitive behavioral assessments in our current battery, as they distinguish both threshold and mTBI categories from sham and demonstrate significant differences between the threshold and mTBI groups. By contrast, significant changes in open field thigmotactic behavior and motor competency were observed only in the mTBI category. Although considerable future studies will be needed to refine the animal model behavioral assessments to more closely resemble the clinical criteria used for mTBI classification, the data presented here serve as a starting point for this effort.
Although neuroimaging outcomes were beyond the scope of the present study, we anticipate observing white matter changes using neuroimaging based on our observation of robust white matter histopathological changes induced by CHIMERA. Consistent with our previous report of axonal damage and white matter inflammation after double TBI at 0.5 J (Namjoshi et al., 2014) , here we observed impact energy-dependent increases in silver uptake in several white matter regions including the olfactory nerve layer, corpus callosum, and optic tract, with significantly increased argyrophilic axons in all regions examined for the mTBI category. Several white matter regions also displayed significant Iba1 reactivity. Our analyses also revealed that both axonal injury and white matter inflammation continued to evolve over 14 d postinjury. Interestingly, we observed transient but significant increases in the number of GFAP-positive astrocytes only in the corpus callosum within 2-7 days post-TBI, suggesting GFAP may be a less sensitive marker of axonal damage than either Iba1 or silver uptake. Several additional histological markers of axonal injury, including neurofilament, amyloid precursor protein, and tau, will be examined in future studies and related to neuroimaging changes. Future studies will also address post-TBI outcomes over chronic periods (N14 d), and assess how age at injury and sex influence post-TBI outcomes.
The response of tau to single vs repetitive mTBI now becomes an important question. Perivascular tau deposits, particularly in sulcal depths, is the pathognomonic feature of CTE (McKee et al., 2016) . Biomarker studies, most commonly performed in studies in athletes who participate in high impact sports, also report that blood tau levels can be used as a diagnostic biomarker for mTBI (Bogoslovsky et al., 2016; Oresic et al., 2016; Shahim et al., 2016; Zetterberg and Blennow, 2016) . Using Western blotting, we previously observed transient phosphorylation of tau in a study that used 2 × 0.5 J impacts, which we now define as the threshold for injury (Namjoshi et al., 2014) . Using a more quantitative ELISA assay, here we observed that single impact TBI up to 0.7 J does not lead to significant increases in total or phosphorylated (Thr231) tau, at least in the acute 14 d period studied here, despite robust silver uptake. This observation raises the important question of whether tau changes may become more robust as a function of cumulative injury, which can be rigorously tested using the CHIMERA platform.
Our data suggest that not all affected white matter regions recover at the same rate (Fig. S9) . The most striking example of this is in the olfactory nerve layer, which displays both a larger dynamic range of histopathologic changes and a faster recovery than any other white matter region studied. On the other end of the spectrum is the corpus callosum, which appears to develop a modest but relatively stable phenotype. In our study, the later bloomer of white matter pathology is the optic tract, which has not yet peaked with respect to silver uptake at the 14 d time point used here, and is consistent with our previous report using double 0.5 J impacts. Future studies that refine the dynamic range and temporal profiles of additional markers in white matter regions, and relate them to neuroimaging findings, will be an important future avenue of investigation.
Our study is limited to describing the associations of impact energy with acute behavioral, neuropathological and biochemical outcomes using single impact CHIMERA in the sagittal plane. Under these conditions, we observed that linear kinematic values were better predictors of biological outcomes than angular kinematic values. Future studies will leverage the ability of CHIMERA to precisely deliver impact in any desired plane to investigate the relationships between lateral impact, which will induce head acceleration-deceleration in the coronal plane, and mTBI outcomes. The threshold of injury for mice is 0.5 J, which produced an average peak linear head velocity of 6.8 m/s, peak linear acceleration of 524 g, peak angular velocity of 326 rad/s, and peak angular acceleration of 149 krad/s 2 . Scaling these mechanical insults based on an equal stress equal velocity relationship and single scale factor of 13.8 (λ) (Panzer et al., 2014) , results in the following equivalent human head kinematics values: peak linear acceleration of 38 g, peak angular velocity of 23.6 rad/s and peak angular acceleration of 782 rad/s 2 . Peak linear head acceleration of 38 g is below most reported human concussion tolerances generated through instrumented helmet data (Guskiewicz et al., 2007; Rowson et al., 2012; Sinha et al., 1968) but above measured head accelerations in volunteer soccer heading (23.5 g) (Shewchenko et al., 2005) and low speed (16 km/h) rear impact vehicle crashes (17.2 g) (Szabo and Welcher, 1996) . Scaled peak angular velocity was in the range reported to result in human concussion, however, peak angular acceleration was well below threshold levels developed from analysis of sports collisions. The average sub-concussive impact in an American football study had a rotational acceleration of 1230 rad/s 2 and a rotational velocity of 5.5 rad/s, while the average concussive impact had a rotational acceleration of 5022 rad/s 2 and a rotational velocity of 22.3 rad/s (Rowson et al., 2012) . Based on reconstructed head impacts in Australian football, a 50% likelihood for concussion was proposed for peak linear acceleration of 65.1 g, peak angular velocity of 22.2 rad/s and peak angular acceleration of 3958 rad/s 2 (McIntosh et al., 2014) . One possible interpretation of the present results, given that linear kinematic values were better predictors of biological outcomes than angular kinematics, is that impact in the sagittal plane generates limited rotational motion. As CHIMERA can generate precise impact in additional planes of motion, future studies will be able to address how injury tolerance may vary by anatomical plane of movement. Additional studies will also address current limitations in scaling animal model mechanical insults to humans. Biomechanical scaling techniques, while remarkably successful in some applications, have yet to be experimentally validated across a range of species (Panzer et al., 2014) . The initiation of skull fractures at impact energies N0.7 J posed an upper ethical limit to our current experimental protocol. In order to produce pathology indicative of more severe brain injury, it will be necessary to induce larger head accelerations while simultaneously decreasing skull fracture risk. Increased skull stiffness and failure strength of murine cranial bones is expected by distribution of impact forces over a greater area of the mouse skull, as has been demonstrated in human cadaver cranium impact tests (Allsop et al., 1991) . Our data support CHIMERA as a useful model of several mTBI subcategories, and confirm DAI as a key neuropathology associated with mTBI. By defining the impact energy parameters at the threshold of mild injury, we are now poised to launch several additional studies to further refine our understanding of the tissue level mechanisms of mTBI and repair.
Supplementary data to this article can be found online at http://dx. doi.org/10.1016/j.expneurol.2017.03.003.
